A detailed history of Merriman Wealth Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Merriman Wealth Management, LLC holds 1,873 shares of AMGN stock, worth $603,499. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,873
Previous 1,773 5.64%
Holding current value
$603,499
Previous $504,000 16.07%
% of portfolio
0.03%
Previous 0.02%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$262.75 - $319.31 $26,275 - $31,931
100 Added 5.64%
1,873 $585,000
Q1 2024

May 14, 2024

BUY
$268.87 - $324.56 $47,321 - $57,122
176 Added 11.02%
1,773 $504,000
Q3 2023

Nov 13, 2023

SELL
$218.65 - $271.46 $10,495 - $13,030
-48 Reduced 2.92%
1,597 $429,000
Q2 2023

Aug 14, 2023

SELL
$214.27 - $253.37 $2,571 - $3,040
-12 Reduced 0.72%
1,645 $365,000
Q1 2023

May 04, 2023

SELL
$225.79 - $275.2 $3,386 - $4,128
-15 Reduced 0.9%
1,657 $400,000
Q4 2022

Feb 13, 2023

SELL
$229.03 - $291.01 $36,644 - $46,561
-160 Reduced 8.73%
1,672 $439,000
Q2 2022

Jul 29, 2022

BUY
$230.71 - $256.74 $7,152 - $7,958
31 Added 1.72%
1,832 $445,000
Q1 2022

Apr 28, 2022

SELL
$219.27 - $242.57 $47,581 - $52,637
-217 Reduced 10.75%
1,801 $436,000
Q4 2021

Feb 01, 2022

BUY
$198.88 - $227.6 $98,644 - $112,889
496 Added 32.59%
2,018 $454,000
Q4 2021

Feb 01, 2022

SELL
$198.88 - $227.6 $1,789 - $2,048
-9 Reduced 0.59%
1,522 $371,000
Q3 2021

Nov 09, 2021

BUY
$212.27 - $248.7 $1,910 - $2,238
9 Added 0.59%
1,531 $326,000
Q2 2021

Jul 28, 2021

SELL
$233.58 - $259.14 $28,963 - $32,133
-124 Reduced 7.53%
1,522 $371,000
Q1 2021

May 10, 2021

SELL
$221.91 - $258.6 $13,092 - $15,257
-59 Reduced 3.46%
1,646 $410,000
Q4 2020

Feb 10, 2021

BUY
$216.38 - $257.67 $54,527 - $64,932
252 Added 17.34%
1,705 $392,000
Q3 2020

Oct 26, 2020

SELL
$234.65 - $260.95 $4,693 - $5,219
-20 Reduced 1.36%
1,453 $369,000
Q2 2020

Jul 31, 2020

SELL
$197.81 - $242.74 $48,859 - $59,956
-247 Reduced 14.36%
1,473 $347,000
Q1 2020

Apr 22, 2020

BUY
$182.24 - $241.7 $313,452 - $415,724
1,720 New
1,720 $349,000
Q2 2019

Jul 31, 2019

SELL
$166.7 - $195.41 $199,039 - $233,319
-1,194 Closed
0 $0
Q1 2019

Apr 23, 2019

SELL
$180.87 - $203.88 $23.5 Million - $26.5 Million
-130,086 Reduced 99.09%
1,194 $227,000
Q4 2018

Jan 28, 2019

SELL
$178.4 - $208.25 $254,576 - $297,172
-1,427 Reduced 1.08%
131,280 $25.7 Million
Q3 2018

Nov 06, 2018

SELL
$185.29 - $208.89 $22,975 - $25,902
-124 Reduced 0.09%
132,707 $27.5 Million
Q1 2018

Apr 10, 2018

SELL
$169.43 - $198.0 $248,384 - $290,268
-1,466 Reduced 1.09%
132,831 $22.6 Million
Q4 2017

Feb 05, 2018

SELL
$168.79 - $188.59 $2.18 Million - $2.43 Million
-12,892 Reduced 8.76%
134,297 $23.4 Million
Q3 2017

Oct 19, 2017

SELL
$167.29 - $191.0 $16,561 - $18,909
-99 Reduced 0.07%
147,189 $27.4 Million
Q2 2017

Aug 07, 2017

BUY
N/A
147,288
147,288 $25.4 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $172B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Merriman Wealth Management, LLC Portfolio

Follow Merriman Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Merriman Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Merriman Wealth Management, LLC with notifications on news.